Alumis (ALMS) Other Accumulated Expenses (2023 - 2025)
Alumis (ALMS) reported Other Accumulated Expenses of $22.3 million for Q4 2025, up 14015.82% year-over-year from N/an in Q4 2024, and up 35301.59% quarter-over-quarter from $63000.0 in Q3 2025.
Alumis (ALMS) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Other Accumulated Expenses data on file, last reported at $22.3 million in Q4 2025.
- Other Accumulated Expenses for Q4 2025 came in at $22.3 million, up 14015.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $22.3 million (up 14015.82% YoY), and the FY2025 annual result was $22.3 million, up 14015.82% from the prior year.
- Other Accumulated Expenses advanced to $22.3 million in Q4 2025 per ALMS's latest filing, from $63000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $22.8 million in Q2 2025 and troughed at $63000.0 in Q3 2025.
- A 3-year average of $9.5 million and a median of $7.6 million in 2023 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses sank 97.77% in 2024, then jumped 14015.82% in 2025.
- A 3-year view of Other Accumulated Expenses shows it stood at $7.1 million in 2023, then slumped by 97.77% to $158000.0 in 2024, then jumped by 14015.82% to $22.3 million in 2025.
- Business Quant data shows ALMS's Other Accumulated Expenses at $22.3 million in Q4 2025, $63000.0 in Q3 2025, and $22.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.30 Mn |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 22.81 Mn |
| Mar 31, 2025 | 15.73 Mn |
| Dec 31, 2024 | 158,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 8.12 Mn |
| Dec 31, 2023 | 7.09 Mn |